Skip to Content
Merck
  • Unusual activity pattern of leucine aminopeptidase inhibitors based on phosphorus containing derivatives of methionine and norleucine.

Unusual activity pattern of leucine aminopeptidase inhibitors based on phosphorus containing derivatives of methionine and norleucine.

Journal of enzyme inhibition and medicinal chemistry (2010-06-29)
Jan Pícha, Radek Liboska, Miloš Buděšínský, Jiři Jiráček, Małgorzata Pawełczak, Artur Mucha
ABSTRACT

Ligands containing bulky aliphatic P1 residues exhibit a high affinity towards cytosolic leucine aminopeptidase, a bizinc protease of biomedical significance. According to this specificity, a series of phosphonic and phosphinic compounds have been put forward as novel putative inhibitors of the enzyme. These phosphonic and phosphinic compounds were derivatives of methionine and norleucine as both single amino acids and dipeptides. The designed inhibitors were synthesised and tested towards the peptidase isolated from porcine kidneys using an improved separation procedure affording superior homogeneity. Unexpectedly, organophosphorus derivatives of methionine and norleucine exhibited moderate activity with K(i) values in the micromolar range.

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
L-Norleucine, ≥98% (TLC)
Sigma-Aldrich
L-Norleucine, suitable for amino acid analysis, BioReagent